Skandinaviska Enskilda Banken AB publ Sells 4,200 Shares of Danaher Co. (DHR)

Skandinaviska Enskilda Banken AB publ lowered its stake in Danaher Co. (NYSE:DHR) by 3.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 105,856 shares of the conglomerate’s stock after selling 4,200 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Danaher were worth $11,502,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the company. Penserra Capital Management LLC grew its stake in shares of Danaher by 355.1% in the third quarter. Penserra Capital Management LLC now owns 20,135 shares of the conglomerate’s stock valued at $2,187,000 after buying an additional 15,711 shares in the last quarter. Chicago Partners Investment Group LLC grew its stake in shares of Danaher by 17.9% in the third quarter. Chicago Partners Investment Group LLC now owns 4,607 shares of the conglomerate’s stock valued at $446,000 after buying an additional 700 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Danaher by 6.2% in the third quarter. Janney Montgomery Scott LLC now owns 118,488 shares of the conglomerate’s stock valued at $12,875,000 after buying an additional 6,897 shares in the last quarter. Zevin Asset Management LLC grew its stake in shares of Danaher by 1.2% in the third quarter. Zevin Asset Management LLC now owns 66,944 shares of the conglomerate’s stock valued at $7,274,000 after buying an additional 771 shares in the last quarter. Finally, Flossbach Von Storch AG grew its stake in shares of Danaher by 3.2% in the third quarter. Flossbach Von Storch AG now owns 5,729,830 shares of the conglomerate’s stock valued at $622,603,000 after buying an additional 180,025 shares in the last quarter. Institutional investors and hedge funds own 76.80% of the company’s stock.

A number of equities research analysts have recently issued reports on DHR shares. Bank of America set a $113.00 target price on Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research note on Monday, July 23rd. Robert W. Baird lowered their price objective on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research note on Friday, October 19th. Morgan Stanley raised their price objective on Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Finally, Royal Bank of Canada raised their price objective on Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. One analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $112.14.

Shares of NYSE DHR opened at $104.39 on Friday. Danaher Co. has a fifty-two week low of $91.65 and a fifty-two week high of $110.13. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38. The company has a market cap of $72.94 billion, a price-to-earnings ratio of 25.90, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The firm had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. Danaher’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.00 EPS. Equities analysts expect that Danaher Co. will post 4.51 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 26th. Stockholders of record on Friday, September 28th were given a $0.16 dividend. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. Danaher’s payout ratio is 15.88%.

In other news, EVP William K. Daniel sold 29,784 shares of Danaher stock in a transaction that occurred on Thursday, October 25th. The stock was sold at an average price of $98.04, for a total value of $2,920,023.36. Following the completion of the transaction, the executive vice president now owns 141,892 shares in the company, valued at approximately $13,911,091.68. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction that occurred on Tuesday, October 23rd. The stock was sold at an average price of $95.77, for a total value of $1,013,055.06. Following the completion of the transaction, the director now owns 105,491 shares of the company’s stock, valued at approximately $10,102,873.07. The disclosure for this sale can be found here. In the last quarter, insiders sold 150,007 shares of company stock valued at $15,202,163. Insiders own 11.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Skandinaviska Enskilda Banken AB publ Sells 4,200 Shares of Danaher Co. (DHR)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/11/10/skandinaviska-enskilda-banken-ab-publ-sells-4200-shares-of-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Article: How to interpret a stock’s beta number

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply